JH8-33355-93204
4 vaccinations
3 coded responses
30 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 731 / OK
- Registered
- 2021-03-08
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-08
Registered in v-safe
-
2021-03-08
Dose 1 — Moderna
- 2021-03-08
-
2021-03-09
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-03-11
- 2021-03-12
- 2021-03-14
- 2021-03-15
- 2021-03-22
- 2021-03-31
-
2021-04-05
Dose 2 — Moderna
-
2021-04-05
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-07
- 2021-04-08
- 2021-04-10
- 2021-04-14
- 2021-04-21
- 2021-04-26
- 2021-05-03
- 2021-05-12
- 2021-05-17
- 2021-07-05
- 2021-10-04
-
2021-12-12
Dose 3 — Moderna
-
2022-04-05
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Miscarriage at 11 weeks pregnant on 1/5/2022. Booster shot received on 12/12/2021.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-05
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
- 2022-04-06
-
2022-04-08
Call successfulParticipant prefers to complete VAERS report online
-
2022-11-13
Dose 4 — Pfizer-BioNTech
-
2022-11-18
Survey response — days 1–6 daily, dose 4MedDRA: Pregnancy — Feeling: GoodFree text: Pregnant 17 weeksMedDRA releases: 2024-11 · check-in free text available
-
2022-11-20
Survey response — day 7, dose 4MedDRA: Pregnancy — Feeling: GoodFree text: Pregnant 18 weeksMedDRA releases: 2024-11 · check-in free text available
- 2022-11-27
- 2022-12-04
- 2022-12-13
- 2022-12-18
- 2022-12-26
- 2023-02-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-08 | Moderna | |
| 2 | 2021-04-05 | Moderna | |
| 3 | 2021-12-12 | Moderna | No |
| 4 | 2022-11-13 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-05 | Successful 2022-04-08 |
Participant prefers to complete VAERS report online |
Free text
Release 11 — 12 months, dose 2
Symptoms: Miscarriage at 11 weeks pregnant on 1/5/2022. Booster shot received on 12/12/2021.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Pregnant 17 weeks
Release 12 — day 7, dose 4
Systemic reaction (other): Pregnant 18 weeks
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SRO | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release